RT Journal Article SR Electronic T1 Study of Epidemiological Characteristics and In-silico Analysis of the Effect of Interventions in the SARS-CoV-2 Epidemic in India JF medRxiv FD Cold Spring Harbor Laboratory Press SP 2020.04.05.20053884 DO 10.1101/2020.04.05.20053884 A1 Mazumder, Archisman A1 Bharadiya, Vishwesh A1 Berry, Parul A1 Arora, Mehak A1 Agarwal, Mudit A1 Gupta, Mohak A1 Behera, Priyamadhaba YR 2020 UL http://medrxiv.org/content/early/2020/04/07/2020.04.05.20053884.abstract AB After SARS-CoV-2 set foot in India, the Indian Government took a number of steps to limit the spread of the disease in the country. This study involves assessing how the disease affected the population in the initial days of the epidemic. Data was collected from government controlled and crowdsourced websites and then put through analysis and calculations. With a study on age and sex parameters of 413 patients, the median age of the affected individuals was found out to be 36 years (IQR 25-54 years) with 20-39 years males being the most affected group. The number of affected males (66.34%) was more than that of the females(33.66%).Using SIR model, the range of contact rate(β) of India was calculated and the role of public health interventions was assessed which proved that the interventions were effective for a little while but the effect reduced due to violations.Article Summary Line The 21 day lockdown in India to slow the COVID 19 epidemic in the country has still not shown significant results, but the earlier interventions done are showing their effect now.Competing Interest StatementThe authors have declared no competing interest.Funding StatementNo funding recievedAuthor DeclarationsAll relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.YesAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesData taken from publicly available crowdsourced and government databases https://www.covid19india.org/